Cerus Corporation
CERS
#7781
Rank
$0.37 B
Marketcap
$1.93
Share price
-5.85%
Change (1 day)
49.61%
Change (1 year)

P/E ratio for Cerus Corporation (CERS)

P/E ratio as of April 2026 (TTM): -24.1

According to Cerus Corporation's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -24.125. At the end of 2024 the company had a P/E ratio of -14.0.

P/E ratio history for Cerus Corporation from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-14.0
2022-14.6-33.54%
2021-22.014.28%
2020-19.2136.86%
2019-8.12-29.57%
2018-11.590.91%
2017-6.04-13.97%
2016-7.02-35.61%
2015-10.9-13.89%
2014-12.725.56%
2013-10.1-4.32%
2012-10.5

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Boston Scientific
BSX
30.4-225.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
19.5-180.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
16.5-168.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-0.0025-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.